]>
IRCT20180612040073N5 IRCT 2019-05-06 University of Sistan and Baluchestan Effect of 8 Endurance and Combined Training on Fetuin-A, TGF-β and Metabolic Syndrome The Effect of 8 Weeks Endurance and Combined Training on Serum Levels of Fetuin-A, Transforming growth factor beta )TGF-β( and Metabolic Syndrome in Overweight and Obese Women 2018-10-23 anticipated 45 Complete https://irct.ir/trial/38875 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization method: Simple Random unit: Individual Randomization Tool: Sealed Envelope. 3 Overweight and Obesity. Intervention 1: Intervention group: Endurance Exercise. Intervention 2: Intervention group: Combined exercises (Endurance and Resistance). Intervention 3: Control group: . Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.
public Majid Vahidian-Rezazadeh
No. 129, Pardisan 1 Ave, University Residential Complex, Daneshgah Blvd
Zahedan Iran (Islamic Republic of) 9816744687 +98 54 3341 6107 vahidian@ped.usb.ac.ir University of Sistan and Baluchestan scientific Majid Vahidian-Rerzazadeh
No. 129, Pardisan 1 Ave, University Residential Complex, Daneshgah Blvd
Zahedan Iran (Islamic Republic of) 9816744687 +98 54 3341 6107 vahidian@ped.usb.ac.ir University of Sistan and Baluchestan Iran (Islamic Republic of) Healthy People Inactive Non-Smoking Not Using Diet And Medicines To Lose Weight Body mass index greater than 25 30 years 45 years Female Heart disease Respiratory problems Joint pains Use of Metabolic Drugs E66 Overweight and obesity Treatment - Other Treatment - Other Treatment - Other Intervention group: Endurance Exercise Intervention group: Combined exercises (Endurance and Resistance) Control group: Fetuin A Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Fetuin A" test kit. Transforming growth factor beta. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Transforming growth factor beta" test kit. Triglyceride. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Triglyceride" test kit. Low-density lipoprotein (LDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "LDL" test kit. High-density lipoprotein (HDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "HDL" test kit. Cholesterol. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Cholesterol" test kit. Subcutaneous fat. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Using the Caliper. Body mass index. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Based on the formula "Weight divided by height squared". University of Sistan and Baluchestan Approved 2019-03-10 Ethics committee of Zahedan University of Medical Sciences Ali Ebn Abitaleb Hospital, Salamat Blvd., Persian Gulf Highway Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)